Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

Pellegrino Musto, Alessandro Levis, Vittorio Simeon et al.|British Journal of Haematology|2017

Cited by 25